PRNP and prion disease: At that time, a wealth of evidence was gathered indicating that the clinical and pathological features of prion disease depend on two major molecular determinants: the PRNP genotype, which is specified by mutations and polymorphic sites, and the physicochemical properties (see paragraphs 3 and 4) of the PrPSc aggregates that accumulate in the affected tissues.